FeesSafety
Pluang+

Atos secures contract to manage and unify France's shared medical records platform with Mon Espace Santé.

Market News
17 Nov 2026, 16:00 WIB
Atos
View Source
Bullish
Atos secures contract to manage and unify France's shared medical records platform with Mon Espace Santé.

Atos has been selected by France's Caisse nationale de l’Assurance Maladie (Cnam) to manage and secure the Dossier Médical Partagé (DMP) and integrate it with Mon Espace Santé (MES) into a unified digital health platform. This platform, serving over 60 million insured individuals, aims to enhance secure data sharing between patients and healthcare professionals, improve care coordination, and reduce redundant medical procedures. Atos will also renew services for MES, leveraging its expertise in cybersecurity and digital sovereignty, with the goal of reaching 40 million active profiles by the end of 2027. The project highlights Atos' role in advancing France's digital health infrastructure with a focus on security and interoperability.

The news about Atos leading the integration of Dossier Médical Partagé with Mon Espace Santé provides context for readers interested in digital health developments. For readers following Health-sector stocks, here is Pluang's market snapshot as of Nov 17, 2026 15:51 WIB: out of 150 priced US health stocks, 39 rose and 106 fell. Notable movers include EXEL at USD 65.50 with a 1-day change of -5.07% and 100% sell order activity, TNGX at USD 24.22 down 5.02%, and ERAS at USD 14.95 down 4.57% with 100% sell order activity.

More News

Atos completes integration of France's Shared Medical Record with Mon Espace Santé platform

Atos completes integration of France's Shared Medical Record with Mon Espace Santé platform

Atos has successfully transitioned and integrated France's Shared Medical Record (DMP) with the Mon Espace Santé (MES) platform, creating a unified, secure digital health infrastructure for over 60 million insured people. This integration supports th...

Market News
Bullish
12 minutes ago
Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics secured $60 million in seed funding led by Ackermans & van Haaren with participation from AbbVie Ventures, M Ventures, and others. The funds will support clinical development of COM002, a first-in-class immune engager targeting cance...

Company Fundamentals
Bullish
3 hours ago
Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes announced at its 2026 Capital Markets Day a new growth cycle aiming for double-digit revenue and EPS growth by 2029, targeting over €8 billion in revenue and €1.80 in non-IFRS diluted EPS. The company highlights its transition to su...

Market News
Bullish
3 hours ago
Dassault Systèmes targets double-digit revenue and EPS growth by 2029, driven by AI and subscription model.

Dassault Systèmes targets double-digit revenue and EPS growth by 2029, driven by AI and subscription model.

Dassault Systèmes announced a new growth cycle aiming for double-digit increases in revenue and diluted EPS by 2029, with revenue expected to exceed €8 billion and EPS €1.80. This growth is supported by a strong subscription model, accelerating adopt...

Company Fundamentals
Bullish
3 hours ago
Allegiant and Sun Country launch 16 new routes for summer 2027, expanding service at MSP and other cities.

Allegiant and Sun Country launch 16 new routes for summer 2027, expanding service at MSP and other cities.

Allegiant Travel Company announced 16 new routes for summer 2027 across Allegiant Air and Sun Country Airlines, which will continue operating separately until 2028 or later. Allegiant will begin serving Minneapolis-Saint Paul International Airport (M...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App